Arecor Therapeutics PLC(GB:AREC)
GBX 77.500.00 (0.00%)
GB:AREC
Arecor Therapeutics PLC financials statements
GBX 77.50
At close:0.00 (0.00%)
Want to see GB:AREC full AI Analyst Report?
Arecor Therapeutics PLC (AREC) Income Statement
6 Followers
Arecor Therapeutics PLC Income Statement
Last quarter (Q2 2026), Arecor Therapeutics PLC's total revenue was £194.00K, a decrease of 90.28% from the same quarter last year. In Q2, Arecor Therapeutics PLC's net income was £-2.98M. See Arecor Therapeutics PLC’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| £ 1.71M | £ 5.05M | £ 4.57M | £ 2.40M | £ 1.16M | |
| £ 1.05M | £ 1.54M | £ 4.57M | £ 2.40M | £ 1.16M | |
| £ 5.72M | £ 12.24M | £ 13.75M | £ 12.91M | £ 7.13M | |
| Depreciation and Amortization | £ 215.00K | £ 446.00K | £ 496.00K | £ 341.00K | £ 171.00K |
| £ -4.45M | £ -10.15M | £ -8.39M | £ -10.06M | £ -6.27M | |
| £ -4.67M | £ -10.70M | £ -9.18M | £ -11.66M | £ -5.98M | |
| £ 5.66M | £ 79.00K | £ 274.00K | £ 88.00K | £ -506.00K | |
| £ 994.00K | £ -10.62M | £ -8.90M | £ -10.54M | £ -6.95M | |
| £ 664.00K | £ -10.24M | £ -8.55M | £ -9.26M | £ -6.17M | |
| Per Share Metrics | |||||
| Basic EPS | £ 0.02 | £ -0.31 | £ -0.28 | £ -0.32 | £ -0.27 |
| Diluted EPS | £ 0.02 | £ -0.31 | £ -0.28 | £ -0.32 | £ -0.27 |
| Weighted Average Shares Outstanding | 37.76M | 33.44M | 30.62M | 28.94M | 23.03M |
| Weighted Average Shares Outstanding (Diluted) | 39.44M | 33.44M | 30.62M | 28.94M | 23.03M |
Currency in GBP
